Mitchell P - Search Results

1

A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.

Van Der Walt A, Sung S, Spelman T, Marriott M, Kolbe S, Mitchell P, Evans A, Butzkueven H. Van Der Walt A, et al. Among authors: mitchell p. Neurology. 2012 Jul 3;79(1):92-9. doi: 10.1212/WNL.0b013e31825dcdd9. Neurology. 2012. PMID: 22753445 Clinical Trial.

2

Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy.

Taylor I, Butzkueven H, Litewka L, MacGregor LR, Szoeke C, Cook M, Mitchell P, Kilpatrick TJ, Tubridy N. Taylor I, et al. Among authors: mitchell p. J Clin Neurosci. 2004 Feb;11(2):153-8. doi: 10.1016/s0967-5868(03)00145-0. J Clin Neurosci. 2004. PMID: 14732374

3

Cladribine followed by autologous stem-cell transplantation in progressive multiple sclerosis.

Grigg A, Tubridy NJ, Szer J, Mitchell P, Butzkueven H, Shuttleworth P, Kilpatrick T. Grigg A, et al. Among authors: mitchell p. Intern Med J. 2004 Jan-Feb;34(1-2):66-9. doi: 10.1111/j.1444-0903.2004.00516.x. Intern Med J. 2004. PMID: 14748917

4

Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapses.

Chapman C, Tubridy N, Cook MJ, Mitchell PJ, MacGregor LR, Lovelock C, Litewka L, Sedal L, Kilpatrick TJ, Butzkueven H. Chapman C, et al. Among authors: mitchell pj. J Clin Neurosci. 2006 Jul;13(6):636-8. doi: 10.1016/j.jocn.2005.08.012. Epub 2006 Jun 21. J Clin Neurosci. 2006. PMID: 16790352 Clinical Trial.

5

Validation of linear cerebral atrophy markers in multiple sclerosis.

Butzkueven H, Kolbe SC, Jolley DJ, Brown JY, Cook MJ, van der Mei IA, Groom PS, Carey J, Eckholdt J, Rubio JP, Taylor BV, Mitchell PJ, Egan GF, Kilpatrick TJ. Butzkueven H, et al. Among authors: mitchell pj. J Clin Neurosci. 2008 Feb;15(2):130-7. doi: 10.1016/j.jocn.2007.02.089. J Clin Neurosci. 2008. PMID: 18068987

6

Vasogenic oedema with no mass lesion.

Lim SY, Wesley Thevathasan A, Gonzales M, Mitchell PJ, Evans A. Lim SY, et al. J Clin Neurosci. 2008 Sep;15(9):1048, 1075-6. doi: 10.1016/j.jocn.2006.11.024. J Clin Neurosci. 2008. PMID: 18782917 No abstract available.

7

Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.

Kolbe S, Chapman C, Nguyen T, Bajraszewski C, Johnston L, Kean M, Mitchell P, Paine M, Butzkueven H, Kilpatrick T, Egan G. Kolbe S, et al. Among authors: mitchell p. Neuroimage. 2009 Apr 15;45(3):679-86. doi: 10.1016/j.neuroimage.2008.12.047. Epub 2009 Jan 7. Neuroimage. 2009. PMID: 19162205

8

Diffusion tensor imaging of the optic radiations after optic neuritis.

Kolbe S, Bajraszewski C, Chapman C, Nguyen T, Mitchell P, Paine M, Butzkueven H, Johnston L, Kilpatrick T, Egan G. Kolbe S, et al. Among authors: mitchell p. Hum Brain Mapp. 2012 Sep;33(9):2047-61. doi: 10.1002/hbm.21343. Epub 2011 Sep 13. Hum Brain Mapp. 2012. PMID: 21915943 Free PMC article.

9

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

Stein MS, Liu Y, Gray OM, Baker JE, Kolbe SC, Ditchfield MR, Egan GF, Mitchell PJ, Harrison LC, Butzkueven H, Kilpatrick TJ. Stein MS, et al. Among authors: mitchell pj. Neurology. 2011 Oct 25;77(17):1611-8. doi: 10.1212/WNL.0b013e3182343274. Neurology. 2011. PMID: 22025459 Clinical Trial.

10

Diffusion tensor imaging correlates of visual impairment in multiple sclerosis and chronic optic neuritis.

Kolbe SC, Marriott M, Walt Av, Fielding J, Klistorner A, Mitchell PJ, Butzkueven H, Kilpatrick TJ, Egan GF. Kolbe SC, et al. Invest Ophthalmol Vis Sci. 2012 Feb 21;53(2):825-32. doi: 10.1167/iovs.11-8864. Invest Ophthalmol Vis Sci. 2012. PMID: 22247457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,415 results

Search Page

Filters